Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article he and his colleagues co-authored, adding:
“I’m pleased to share our recent paper, ‘Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?’ published in Therapeutic Advances in Hematology.
It was a privilege to work on this with Robert Sidonio, Fernando Corrales-Medina, Jill Johnsen, Michelle Sholzberg, and Caroline Malcolmson.
In this review, we examine why prophylaxis in von Willebrand disease has historically lagged behind established practice in hemophilia, despite a substantial bleeding burden in patients with severe and recurrent disease.
We discuss barriers to broader implementation, review emerging clinical evidence supporting prophylactic VWF replacement, and argue that the field is moving toward a more individualized, phenotype-driven approach that may help bring VWD care closer to parity with hemophilia.
Recent prospective data and regulatory progress suggest that prophylaxis should be considered more systematically for appropriately selected patients.
Thank you to Octapharma for supporting the medical writing assistance for this publication.”
Title: Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Authors: Robert F. Sidonio Jr., Fernando F. Corrales-Medina, Jill M. Johnsen, Michelle Sholzberg, Caroline Malcolmson, Nathan T. Connell
Read the Full Article on Therapeutic Advances in Hematology
Other posts featuring Nathan Connell on Hemostasis Today.
-
Jul 17, 2026, 08:32Kathleen Freson: Enjoying the Science, T&H Community and Inspiring SSC Work at ISTH 2026
-
Jul 17, 2026, 08:25David Smadja: What a Week in this Parisian Edition of the ISTH
-
Jul 17, 2026, 04:28Redefining Thromboprophylaxis in Multiple Myeloma: Early VTE Emerges as the Critical Therapeutic Challenge
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026